Impact of enhanced compliance initiatives on the efficacy of rosuvastatin in reducing low density lipoprotein cholesterol levels in patients with primary hypercholesterolaemia.

Source:http://linkedlifedata.com/resource/pubmed/id/18654867

Swiss Med Wkly 2008 Jul 26 138 29-30 420-6

Download in:

View as

General Info

PMID
18654867